Clinical significance of hormonal receptor status of malignant ovarian tumors
Objectives: To study hormonal receptor status (HRS) of malignant ovarian tumors (MOT) and determine its clinical significance. Patients and Methods: Retrospective analysis of case histories of 284 patients with MOT of different genesis of I–IV stages was carried out; immunohistochemical study of par...
Saved in:
| Published in: | Experimental Oncology |
|---|---|
| Date: | 2014 |
| Main Authors: | Tkalia, I.G., Vorobyova, L.I., Svintsitsky, V.S., Nespryadko, S.V., Goncharuk, I.V., Lukyanova, N.Y., Chekhun, V.F. |
| Format: | Article |
| Language: | English |
| Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2014
|
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/145343 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Clinical significance of hormonal receptor status of malignant ovarian tumors / I.G. Tkalia, L.I. Vorobyova, V.S. Svintsitsky, S.V. Nespryadko, I.V. Goncharuk, N.Y. Lukyanova, V.F. Chekhun // Experimental Oncology. — 2014. — Т. 36, № 2. — С. 125-133. — Бібліогр.: 39 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
Clinical significance of hormonal receptor status of malignant ovarian tumors
by: I. G. Tkalia, et al.
Published: (2014)
by: I. G. Tkalia, et al.
Published: (2014)
Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor
by: I. G. Tkalia, et al.
Published: (2014)
by: I. G. Tkalia, et al.
Published: (2014)
Recurrence of borderline ovarian tumors
by: V. S. Svintsitskiy, et al.
Published: (2013)
by: V. S. Svintsitskiy, et al.
Published: (2013)
Recurrence of borderline ovarian tumors
by: Svintsitskiy, V.S., et al.
Published: (2013)
by: Svintsitskiy, V.S., et al.
Published: (2013)
Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
by: Chekhun, S.V., et al.
Published: (2014)
by: Chekhun, S.V., et al.
Published: (2014)
General clinical, biochemical parameters and peripheral blood hormone level in women at ovarian hyperstimulation syndrome
by: N. V. Avramenko, et al.
Published: (2018)
by: N. V. Avramenko, et al.
Published: (2018)
Chemocine receptor CXCR4 expression and microvessels density in malignant tumors of the breast of patients with sings of metabolic syndrome
by: N. P. Yurchenko, et al.
Published: (2020)
by: N. P. Yurchenko, et al.
Published: (2020)
Clinical and immunohistochemical features of primary breast cancer and metachronous ovarian and endometrial tumors
by: Kryzhanivska, A.E., et al.
Published: (2018)
by: Kryzhanivska, A.E., et al.
Published: (2018)
The antitumor efficacy of cisplatin in combination with triptorelin and exemestane therapy for an ovarian cancer ascites model in Wistar rats
by: I. G. Tkalia, et al.
Published: (2015)
by: I. G. Tkalia, et al.
Published: (2015)
Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
by: S. V. Chekhun, et al.
Published: (2014)
by: S. V. Chekhun, et al.
Published: (2014)
The Clinical Significance of Tumor MIR-122, -155, -182, and -200b Expression in Patients with Breast Cancer
by: V. F. Chekhun, et al.
Published: (2017)
by: V. F. Chekhun, et al.
Published: (2017)
Quantitative analysis of SLC34A2 expression in different types of ovarian tumors
by: Shyian, M., et al.
Published: (2011)
by: Shyian, M., et al.
Published: (2011)
Cytomegaloviruses and malignant brain tumors
by: Lisyany, N.I., et al.
Published: (2023)
by: Lisyany, N.I., et al.
Published: (2023)
Ovarian cancer: family cancer syndrome and clinical significance of testing of the mutations in BRCA1 and BRCA2?genes
by: O. V. Paliichuk, et al.
Published: (2016)
by: O. V. Paliichuk, et al.
Published: (2016)
Expression of steroid and peptide hormone receptors, metabolic enzymes and EMT-related genes in prostate tumors in relation to the presence of the TMPRSS2/ERG fusion
by: Gerashchenko, G.V., et al.
Published: (2018)
by: Gerashchenko, G.V., et al.
Published: (2018)
Relationship between malignant tumor metabolism and tumor-bearing organism
by: T. N. Popovskaja, et al.
Published: (2019)
by: T. N. Popovskaja, et al.
Published: (2019)
Hormonal impact on tumor growth and progression
by: Reznikov, A.
Published: (2015)
by: Reznikov, A.
Published: (2015)
Hormonal impact on tumor growth and progression
by: A. Reznikov
Published: (2015)
by: A. Reznikov
Published: (2015)
Hormonal-sensitive breast cancer: molecular-biological and clinical aspects of preoperative antitumor hormone therapy
by: O. V. Ponomareva
Published: (2018)
by: O. V. Ponomareva
Published: (2018)
Clinical hormonal characteristics and therapy of girls with endometrial hyperplasia and anemia
by: I. A. Tuchkina, et al.
Published: (2014)
by: I. A. Tuchkina, et al.
Published: (2014)
Influence of exogenous lactoferrin on the oxidant/ antioxidant balance and molecular profile of hormone receptor-positive and -negative human breast cancer cells in vitro
by: Zalutski, I.V., et al.
Published: (2017)
by: Zalutski, I.V., et al.
Published: (2017)
Vacuum cryo-thermal probe for destruction of malignant tumors
by: M. I. Gasanov, et al.
Published: (2013)
by: M. I. Gasanov, et al.
Published: (2013)
The peculiarities of ultra sound diagnostics of borderline ovarian tumors
by: E. S. Klimenko, et al.
Published: (2014)
by: E. S. Klimenko, et al.
Published: (2014)
Protein and carbohydrate metabolism disorders in patients with malignant tumors of the intestine
by: T. N. Popovskaja, et al.
Published: (2018)
by: T. N. Popovskaja, et al.
Published: (2018)
The phenomenon of multi-drug resistance in the treatment of malignant tumors
by: S. V. Vtorushin, et al.
Published: (2014)
by: S. V. Vtorushin, et al.
Published: (2014)
The phenomenon of multi-drug resistance in the treatment of malignant tumors
by: Vtorushin, S.V., et al.
Published: (2014)
by: Vtorushin, S.V., et al.
Published: (2014)
Nanohyperthermia of malignant tumors. II. In vivo tumor heating with manganese perovskite nanoparticles
by: Bubnovskaya, L., et al.
Published: (2012)
by: Bubnovskaya, L., et al.
Published: (2012)
Genetic and epigenetic changes in malignant cells of tumors of urogenital organs
by: Gordiyuk, V.V.
Published: (2010)
by: Gordiyuk, V.V.
Published: (2010)
Expression of CD40 by the cells of benign and malignant breast tumors and antitumor action of autologous lymphocytes against chemoresistant and chemosensitive tumors
by: Bereznaya, N.M., et al.
Published: (2008)
by: Bereznaya, N.M., et al.
Published: (2008)
Clinical features of patients with syndrome of biologically inactive growth hormone
by: N. A. Sprynchuk
Published: (2019)
by: N. A. Sprynchuk
Published: (2019)
Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis
by: O. D. Ryabtseva, et al.
Published: (2013)
by: O. D. Ryabtseva, et al.
Published: (2013)
Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis
by: Ryabtseva, O.D., et al.
Published: (2013)
by: Ryabtseva, O.D., et al.
Published: (2013)
Laboratory parameters as predictors of bladder tumor malignancy grade
by: L. A. Derzhavets
Published: (2013)
by: L. A. Derzhavets
Published: (2013)
Anti-Muller hormone detection and Doppler study of ovary blood supply in diagnosis of poor ovarian response syndrome
by: V. A. Pitko, et al.
Published: (2013)
by: V. A. Pitko, et al.
Published: (2013)
Individual prognosis of serous ovarian cancer survival patients based on adhesion and proliferation of tumor cells
by: O. D. Ryabtseva, et al.
Published: (2014)
by: O. D. Ryabtseva, et al.
Published: (2014)
Application of Information Technology for Determination of Circulating Tumor Cells to Diagnostics of Malignant Tumor Diseases
by: Yu. Azarkhov, et al.
Published: (2020)
by: Yu. Azarkhov, et al.
Published: (2020)
Expression of proteins of polyamine metabolism ferments in human prostate malignant tumors
by: S. V. Hohol
Published: (2019)
by: S. V. Hohol
Published: (2019)
Nanohyperthermia of malignant tumors.i. lanthanum-strontium manganite magnetic fluid as potential inducer of tumor hyperthermia
by: Solopan, S., et al.
Published: (2011)
by: Solopan, S., et al.
Published: (2011)
Clinical signification of the content of stem cells in brain tumors
by: N. I. Lisjanyj, et al.
Published: (2019)
by: N. I. Lisjanyj, et al.
Published: (2019)
An unusual case of a lesion of the right ventricle of the heart with a malignant tumor
by: R. M. Vitovskij, et al.
Published: (2018)
by: R. M. Vitovskij, et al.
Published: (2018)
Similar Items
-
Clinical significance of hormonal receptor status of malignant ovarian tumors
by: I. G. Tkalia, et al.
Published: (2014) -
Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor
by: I. G. Tkalia, et al.
Published: (2014) -
Recurrence of borderline ovarian tumors
by: V. S. Svintsitskiy, et al.
Published: (2013) -
Recurrence of borderline ovarian tumors
by: Svintsitskiy, V.S., et al.
Published: (2013) -
Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
by: Chekhun, S.V., et al.
Published: (2014)